<p>Ethic Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第三季度将其在美敦力 PLC（NYSE:MDT - 免费报告）的持股比例降低了 7.5%。该基金在季度内出售了 11,006 股后，持有该医疗科技公司 135,412 股股票。根据其最近向美国证券交易委员会提交的文件，Ethic Inc. 在美敦力的持股价值为 12,897,000 美元。</p>
<ul>
<li>美敦力股票找到了立足点——现在正在获得动能</li>
</ul>
<p>其他对冲基金最近也对该公司的持股进行了调整。Mattson Financial Services LLC 在第三季度将其在美敦力的持股增加了 0.6%。Mattson Financial Services LLC 目前持有 46,700 股该医疗科技公司的股票，价值 4,448,000 美元，此前在该期间内又增持了 294 股。Optivise Advisory Services LLC 在第三季度新建了美敦力的持仓，价值约 208,000 美元。Regatta Capital Group LLC 在第三季度将其在美敦力的持股增加了 1.0%。Regatta Capital Group LLC 目前持有 21,347 股该医疗科技公司的股票，价值 2,033,000 美元，此前在该期间内又购买了 220 股。Perigon Wealth Management LLC 在第三季度将其在美敦力的持股增加了 23.8%。Perigon Wealth Management LLC 目前持有 18,366 股该医疗科技公司的股票，价值 1,749,000 美元，此前在上个季度又购买了 3,535 股。最后，Great Oak Capital Partners LLC 在第三季度新建了美敦力的持仓，价值约 604,000 美元。机构投资者和对冲基金持有该公司 82.06% 的股票。</p>
<h2>美敦力价格表现</h2>
<p>美敦力股票周一开盘价为 96.52 美元。该公司的市值为 1237.4 亿美元，市盈率为 26.02，市盈增长比率为 2.54，贝塔值为 0.71。美敦力 PLC 的 52 周低点为 79.29 美元，52 周高点为 106.33 美元。该公司的 50 天简单移动平均线为 97.54 美元，200 天简单移动平均线为 93.80 美元。该公司的速动比率为 1.80，流动比率为 2.42，债务与股本比率为 0.57。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最近一次发布财报是在 11 月 18 日，报告显示该医疗科技公司本季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出 0.05 美元。该公司在本季度的收入为 89.6 亿美元，而市场共识预期为 88.6 亿美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司的季度收入同比增长 6.6%。去年同期，该公司每股收益为 1.26 美元。美敦力已将其 2026 财年的指引设定为每股收益 5.620-5.660 美元。根据分析师的平均预测，美敦力 PLC 本财年的每股收益将为 5.46 美元。</p>
<h2>美敦力分红公告</h2>
<p>该公司最近还披露了季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日的登记投资者将获得每股 0.71 美元的分红。这代表着每年 2.84 美元的分红和 2.9% 的分红收益率。除息日为 12 月 26 日（星期五）。美敦力的派息比率目前为 76.55%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>一些研究分析师最近对 MDT 股票发表了看法。Jefferies Financial Group 在 11 月 19 日的报告中重申了对美敦力的 “持有” 评级，并设定了 110.00 美元的目标价。摩根大通将美敦力的目标价从 90.00 美元上调至 100.00 美元，并在 11 月 13 日的研究报告中给予该股票 “中性” 评级。Leerink Partners 在 11 月 19 日的研究报告中设定了美敦力的目标价为 120.00 美元，并给予该股票 “跑赢大盘” 评级。Weiss Ratings 在 12 月 15 日的研究报告中重申了对美敦力的 “买入（b）” 评级。最后，瑞银集团在 11 月 19 日的研究报告中将美敦力的目标价从 95.00 美元上调至 102.00 美元，并给予该股票 “中性” 评级。一位投资分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位给予了持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 109.94 美元。</p>
<p><strong>查看我们关于 MDT 的最新报告</strong></p>
<h2>关于美敦力</h2>
<p>（免费报告）</p>
<p>美敦力 plc 是一家全球医疗科技公司，开发和制造广泛的治疗设备和医疗解决方案。公司合法注册于爱尔兰，主要运营办公室位于美国，向全球的医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
<p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>请勿删除，立即阅读</li>
<li>富人如何退休</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>100 万美元在退休中能维持多久？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>Ethic Inc. 在第三季度减少了对美敦力（Medtronic PLC）的持股 7.5%，目前持有 135,412 股，价值约为 1290 万美元。其他对冲基金也调整了他们的头寸，有些增加了他们的股份。美敦力的股票开盘价为 96.52 美元，市值为 1237.4 亿美元。该公司报告每股收益为 1.36 美元，超出预期，并宣布季度股息为每股 0.71 美元。分析师对该股票设定了不同的目标价，平均目标价为 109.94 美元，普遍评级为 “适度买入”</p>

<p>Ethic Inc. lowered its position in shares of Medtronic PLC (NYSE:MDT - Free Report) by 7.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 135,412 shares of the medical technology company's stock after selling 11,006 shares during the quarter. Ethic Inc.'s holdings in Medtronic were worth $12,897,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Ethic Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第三季度将其在美敦力 PLC（NYSE:MDT - 免费报告）的持股比例降低了 7.5%。该基金在季度内出售了 11,006 股后，持有该医疗科技公司 135,412 股股票。根据其最近向美国证券交易委员会提交的文件，Ethic Inc. 在美敦力的持股价值为 12,897,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到了立足点——现在正在获得动能</li>
</ul>
</div><p>Other hedge funds also recently made changes to their positions in the company. Mattson Financial Services LLC increased its stake in shares of Medtronic by 0.6% during the third quarter. Mattson Financial Services LLC now owns 46,700 shares of the medical technology company's stock worth $4,448,000 after acquiring an additional 294 shares during the period. Optivise Advisory Services LLC acquired a new position in Medtronic during the 3rd quarter worth approximately $208,000. Regatta Capital Group LLC increased its position in Medtronic by 1.0% during the 3rd quarter. Regatta Capital Group LLC now owns 21,347 shares of the medical technology company's stock worth $2,033,000 after purchasing an additional 220 shares during the period. Perigon Wealth Management LLC raised its stake in shares of Medtronic by 23.8% during the 3rd quarter. Perigon Wealth Management LLC now owns 18,366 shares of the medical technology company's stock worth $1,749,000 after buying an additional 3,535 shares in the last quarter. Finally, Great Oak Capital Partners LLC acquired a new stake in shares of Medtronic in the 3rd quarter valued at approximately $604,000. Institutional investors and hedge funds own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金最近也对该公司的持股进行了调整。Mattson Financial Services LLC 在第三季度将其在美敦力的持股增加了 0.6%。Mattson Financial Services LLC 目前持有 46,700 股该医疗科技公司的股票，价值 4,448,000 美元，此前在该期间内又增持了 294 股。Optivise Advisory Services LLC 在第三季度新建了美敦力的持仓，价值约 208,000 美元。Regatta Capital Group LLC 在第三季度将其在美敦力的持股增加了 1.0%。Regatta Capital Group LLC 目前持有 21,347 股该医疗科技公司的股票，价值 2,033,000 美元，此前在该期间内又购买了 220 股。Perigon Wealth Management LLC 在第三季度将其在美敦力的持股增加了 23.8%。Perigon Wealth Management LLC 目前持有 18,366 股该医疗科技公司的股票，价值 1,749,000 美元，此前在上个季度又购买了 3,535 股。最后，Great Oak Capital Partners LLC 在第三季度新建了美敦力的持仓，价值约 604,000 美元。机构投资者和对冲基金持有该公司 82.06% 的股票。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>美敦力价格表现</h2>
</div><p>Medtronic stock opened at $96.52 on Monday. The firm has a market capitalization of $123.74 billion, a PE ratio of 26.02, a P/E/G ratio of 2.54 and a beta of 0.71. Medtronic PLC has a 52 week low of $79.29 and a 52 week high of $106.33. The firm's 50-day simple moving average is $97.54 and its 200 day simple moving average is $93.80. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57.</p>
<div class="lb-trans"><p>美敦力股票周一开盘价为 96.52 美元。该公司的市值为 1237.4 亿美元，市盈率为 26.02，市盈增长比率为 2.54，贝塔值为 0.71。美敦力 PLC 的 52 周低点为 79.29 美元，52 周高点为 106.33 美元。该公司的 50 天简单移动平均线为 97.54 美元，200 天简单移动平均线为 93.80 美元。该公司的速动比率为 1.80，流动比率为 2.42，债务与股本比率为 0.57。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.05. The firm had revenue of $8.96 billion during the quarter, compared to the consensus estimate of $8.86 billion. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The firm's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period last year, the firm posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities research analysts predict that Medtronic PLC will post 5.46 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最近一次发布财报是在 11 月 18 日，报告显示该医疗科技公司本季度每股收益为 1.36 美元，超出市场共识预期的 1.31 美元，超出 0.05 美元。该公司在本季度的收入为 89.6 亿美元，而市场共识预期为 88.6 亿美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司的季度收入同比增长 6.6%。去年同期，该公司每股收益为 1.26 美元。美敦力已将其 2026 财年的指引设定为每股收益 5.620-5.660 美元。根据分析师的平均预测，美敦力 PLC 本财年的每股收益将为 5.46 美元。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力分红公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Friday, December 26th. Medtronic's payout ratio is currently 76.55%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日的登记投资者将获得每股 0.71 美元的分红。这代表着每年 2.84 美元的分红和 2.9% 的分红收益率。除息日为 12 月 26 日（星期五）。美敦力的派息比率目前为 76.55%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>A number of research analysts recently weighed in on MDT shares. Jefferies Financial Group reaffirmed a &#34;hold&#34; rating and set a $110.00 price objective on shares of Medtronic in a report on Wednesday, November 19th. JPMorgan Chase &amp; Co. boosted their target price on shares of Medtronic from $90.00 to $100.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, November 13th. Leerink Partners set a $120.00 price target on shares of Medtronic and gave the stock an &#34;outperform&#34; rating in a research note on Wednesday, November 19th. Weiss Ratings reiterated a &#34;buy (b)&#34; rating on shares of Medtronic in a research note on Monday, December 15th. Finally, UBS Group upped their target price on shares of Medtronic from $95.00 to $102.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $109.94.</p>
<div class="lb-trans"><p>一些研究分析师最近对 MDT 股票发表了看法。Jefferies Financial Group 在 11 月 19 日的报告中重申了对美敦力的 “持有” 评级，并设定了 110.00 美元的目标价。摩根大通将美敦力的目标价从 90.00 美元上调至 100.00 美元，并在 11 月 13 日的研究报告中给予该股票 “中性” 评级。Leerink Partners 在 11 月 19 日的研究报告中设定了美敦力的目标价为 120.00 美元，并给予该股票 “跑赢大盘” 评级。Weiss Ratings 在 12 月 15 日的研究报告中重申了对美敦力的 “买入（b）” 评级。最后，瑞银集团在 11 月 19 日的研究报告中将美敦力的目标价从 95.00 美元上调至 102.00 美元，并给予该股票 “中性” 评级。一位投资分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位给予了持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 109.94 美元。</p>
</div><p><strong>View Our Latest Report on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 MDT 的最新报告</strong></p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>关于美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.</p>
<div class="lb-trans"><p>美敦力 plc 是一家全球医疗科技公司，开发和制造广泛的治疗设备和医疗解决方案。公司合法注册于爱尔兰，主要运营办公室位于美国，向全球的医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
</div><p>Medtronic's offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).</p>
<div class="lb-trans"><p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（心脏起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统及外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Do not delete, read immediately</li>
<li>How the Rich Retire</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>How Long Will $1M Last in Retirement?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>请勿删除，立即阅读</li>
<li>富人如何退休</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>100 万美元在退休中能维持多久？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Ethic Inc. 减少了其在美敦力公司（Medtronic PLC）的持股 $MDT